KAUST researchers refute challenges to targeted cancer therapy

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

Intra-Cellular reports positive results in depression study aimed at expanding use of antipsychotic medicine

Intra-Cellular Therapies reported positive results Tuesday from a late-stage clinical trial seeking to expand the use of its antipsychotic medicine Caplyta to patients with major

April 16, 2024

Burdock roots outshine dandelion in antidiabetic potential study

Study compares the antidiabetic potential of dandelion and burdock roots, finding burdock exhibits higher total phenolic content and α-amylase activity, while dandelion has higher total

April 8, 2024

DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook – Biotech Investments

DocMorris AG / Key word(s): Quarterly / Interim Statement 19-Oct-2023 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.